C16H21I3N8O4, monoclinic, P21/n (no. 14), a = 14.7257(7) Å, b = 10.5712(5) Å, c = 16.7501(8) Å, β = 114.408(2)°, V = 2374.4(2) Å3, Z = 4, Rgt(F) = 0.0254, wRref(F2) = 0.0760, T = 290(2) K
C32H28N2O3, tridinic, P1 (No. 2), a = 8.648(8) Å, b = 10.27(1)Å, c = 15.31 (2) Å, α = 80.69(3)°, β =...
C24H29N5O, triclinic, P1̄ (no. 2), a = 10.352(9) Å, b = 10.911(10) Å, c = 12.480(6) Å, α = 97.33(2)°...
C19H17IO7, triclinic, P1̅ (no. 2), a = 9.2343(19) Å, b = 10.218(2) Å, c = 10.4199(18) Å, α = 72.629(...
C19H16BF2I3N2, triclinic, P1̄ (no. 2), a = 10.163(1) Å, b = 10.682(1) Å, c = 11.592(1) Å, α = 63.658...
The crystal structure of the low‐temperature form of anhydrous caffeine has been determined by using...
C8H16I5N2O, monoclinic, C2/c (no. 15), a = 34.180(5) Å, b = 7.6817(3) Å, c = 21.421(3) Å, β = 137.93...
H4I3O11Yb, triclinic, P1̅ (no. 2), a = 7.268(1) Å, b = 7.441(1) Å, c = 9.319(1) Å, α = 79.54(1)°, β ...
C22H30F4I2N2O6, monoclinic, P21/n (no. 14), a = 7.6927(3) Å, b = 12.4813(5) Å, c = 15.0763(5) Å, β =...
C12H9I5NO, triclinic, P1 (no. 2), a = 8.6099(5) Å, b = 9.7325(3) Å, c = 12.2098(6) Å, α = 108.972(4)...
C13H13N2O8, triclinic, P1̄ (no. 2), a = 7.8590(6) Å, b = 9.3108(8) Å, c = 11.0816(8) Å, α = 66.950(3...
C6H8IN3O2, monoclinic, P21/n (no. 14), a = 7.0704(3) Å, b = 15.7781(6) Å, c = 9.1495(4) Å, β = 112.1...
C6H9IN2O3, monoclinic, P21/c$P{2}_{1}/c$ (no. 14), a = 9.3654(2) Å, b = 8.0312(2) Å, c = 12.7668(3) ...
C13H11I4NS, monoclinic, C2/c (no. 15), a = 29.508(1) Å, b = 8.3747(3) Å, c = 14.9533(5) Å, β = 105.9...
C21H11F4I2N3, monoclinic, C2/c (no. 15), a = 17.9705(8) Å, b = 6.5423(3) Å, c = 17.8916(8) Å, β = 98...
C24H22Cl3CoN4O4.5, monoclinic, P21/c (no. 14), a = 7.1852(3) Å, b = 17.1435(7) Å, c = 19.9264(9) ...
C32H28N2O3, tridinic, P1 (No. 2), a = 8.648(8) Å, b = 10.27(1)Å, c = 15.31 (2) Å, α = 80.69(3)°, β =...
C24H29N5O, triclinic, P1̄ (no. 2), a = 10.352(9) Å, b = 10.911(10) Å, c = 12.480(6) Å, α = 97.33(2)°...
C19H17IO7, triclinic, P1̅ (no. 2), a = 9.2343(19) Å, b = 10.218(2) Å, c = 10.4199(18) Å, α = 72.629(...
C19H16BF2I3N2, triclinic, P1̄ (no. 2), a = 10.163(1) Å, b = 10.682(1) Å, c = 11.592(1) Å, α = 63.658...
The crystal structure of the low‐temperature form of anhydrous caffeine has been determined by using...
C8H16I5N2O, monoclinic, C2/c (no. 15), a = 34.180(5) Å, b = 7.6817(3) Å, c = 21.421(3) Å, β = 137.93...
H4I3O11Yb, triclinic, P1̅ (no. 2), a = 7.268(1) Å, b = 7.441(1) Å, c = 9.319(1) Å, α = 79.54(1)°, β ...
C22H30F4I2N2O6, monoclinic, P21/n (no. 14), a = 7.6927(3) Å, b = 12.4813(5) Å, c = 15.0763(5) Å, β =...
C12H9I5NO, triclinic, P1 (no. 2), a = 8.6099(5) Å, b = 9.7325(3) Å, c = 12.2098(6) Å, α = 108.972(4)...
C13H13N2O8, triclinic, P1̄ (no. 2), a = 7.8590(6) Å, b = 9.3108(8) Å, c = 11.0816(8) Å, α = 66.950(3...
C6H8IN3O2, monoclinic, P21/n (no. 14), a = 7.0704(3) Å, b = 15.7781(6) Å, c = 9.1495(4) Å, β = 112.1...
C6H9IN2O3, monoclinic, P21/c$P{2}_{1}/c$ (no. 14), a = 9.3654(2) Å, b = 8.0312(2) Å, c = 12.7668(3) ...
C13H11I4NS, monoclinic, C2/c (no. 15), a = 29.508(1) Å, b = 8.3747(3) Å, c = 14.9533(5) Å, β = 105.9...
C21H11F4I2N3, monoclinic, C2/c (no. 15), a = 17.9705(8) Å, b = 6.5423(3) Å, c = 17.8916(8) Å, β = 98...
C24H22Cl3CoN4O4.5, monoclinic, P21/c (no. 14), a = 7.1852(3) Å, b = 17.1435(7) Å, c = 19.9264(9) ...
C32H28N2O3, tridinic, P1 (No. 2), a = 8.648(8) Å, b = 10.27(1)Å, c = 15.31 (2) Å, α = 80.69(3)°, β =...
C24H29N5O, triclinic, P1̄ (no. 2), a = 10.352(9) Å, b = 10.911(10) Å, c = 12.480(6) Å, α = 97.33(2)°...
C19H17IO7, triclinic, P1̅ (no. 2), a = 9.2343(19) Å, b = 10.218(2) Å, c = 10.4199(18) Å, α = 72.629(...
View in ORKG
DOI